Position in NUVB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,313,003
-$3,018,599 QoQ
Shares Held
539,162
-9.4% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. NUVB ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in NUVB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,313,003 | 539,162 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,331,602 | 595,045 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,499,719 | 675,600 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $229,990 | 117,944 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $153,320 | 87,114 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $319,505 | 120,115 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,014,269 | 442,913 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $223,333 | 76,484 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $211,737 | 58,170 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $149,286 | 98,865 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $133,334 | 99,503 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $204,463 | 113,591 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $149,283 | 89,930 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $128,009 | 66,672 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $145,327 | 64,879 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $637,303 | 196,699 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,763,002 | 715,400 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $5,713,878 | 672,221 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $515,477 | 51,859 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $559,799 | 60,129 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||